The role of Epithelial to Mesenchymal Transition (EMT) factor Zeb1 is well defined in metastasis and cancer progression but it's importance in dendritic cells (DCs) is unexplored until now. For the first time we report here that Zeb1 controls immunogenic
Sunil K. Raghav (3259440) +7 more
core +1 more source
The role of Epithelial to Mesenchymal Transition (EMT) factor Zeb1 is well defined in metastasis and cancer progression but it's importance in dendritic cells (DCs) is unexplored until now. For the first time we report here that Zeb1 controls immunogenic
Sunil K. Raghav (3259440) +7 more
core +1 more source
Introduction Tuberculosis due to Mycobacterium tuberculosis (Mtb) kills a million people each year and the widely used BCG vaccine is partially effective.
Fnu Rohini
core +1 more source
FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines
Dendritic cell (DC)-targeted vaccination is a new mode of antigen delivery that relies on the use of monoclonal antibodies (mAb) to target antigen to specific DC subsets.
Christophe Macri +9 more
doaj +1 more source
Die Biosynthese von Glycosylphosphatidylinositol (GPI) und der Transport von GPI-verankerten Proteinen vom ER zur Plasmamembran oder der Zellwand wird in Eukaryoten durch ein komplexes Prozessierungs- und Sortierungsnetzwerk vermittelt, an dem mehr als
Friederichs, Sabrina
core +1 more source
<i>Zbtb46<sup>T11A</sup></i> Mutation Is Associated with Enhanced Influenza Vaccine Immunogenicity and Altered cDC1 Proportions in Mice. [PDF]
Zhao Y +8 more
europepmc +1 more source
Innate immune activation profiles are associated with polarization of the T cell response to recombinant arenaviral vectors. [PDF]
Szaffich S +9 more
europepmc +1 more source
FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancer. [PDF]
Abascal J +16 more
europepmc +1 more source
Epigenetic plus cytokine therapy induces stem-like CD8<sup>+</sup> T-cell reservoirs and intratumoral immune niches to overcome anti-PD-1 resistance. [PDF]
Minnar CM +20 more
europepmc +1 more source
Oncolytic virotherapy with chimeric rVSV-NDV causes tumor-specific immunity in a DC-activation-dependent manner. [PDF]
Hanesch L +4 more
europepmc +1 more source

